{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:55:56Z","timestamp":1792410956687,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015389","name":"Nanovaccine Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015389","id-type":"DOI","asserted-by":"publisher"}]},{"name":"College of Veterinary Medicine Seed Programs"},{"DOI":"10.13039\/100009227","name":"Iowa State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000199","name":"USDA Formula Funds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jconrel.2018.12.024","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T02:21:39Z","timestamp":1545013299000},"page":"288-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Nanotherapeutic provides dose sparing and improved antimicrobial activity against Brucella melitensis infections"],"prefix":"10.1016","volume":"294","author":[{"given":"Paul","family":"Lueth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Haughney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Binnebose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Mullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Peroutka-Bigus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan H.","family":"Bellaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.12.024_bb0005","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2958.2004.04017.x","article-title":"Adaptation of the Brucellae to their intracellular niche","volume":"52","author":"Roop","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0010","first-page":"363","article-title":"Macrophages and brucella","volume":"60","author":"Baldwin","year":"1994","journal-title":"Immunol. Ser."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2013","journal-title":"Front. Biol. (Beijing)"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2003037","article-title":"Rough vaccines in animal brucellosis: structural and genetic basis and present status","volume":"35","author":"Moriyon","year":"2004","journal-title":"Vet. Res."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0025","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1517\/13543784.15.10.1141","article-title":"Future trends in human brucellosis treatment","volume":"15","author":"Pappas","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00003495-199753020-00005","article-title":"Recognition and optimum treatment of brucellosis","volume":"53","author":"Solera","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0035","first-page":"401","article-title":"Human brucellosis","volume":"15","author":"Sauret","year":"2002","journal-title":"J. Am. Board Fam. Pract."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0040","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.0406873102","article-title":"Brucella coopts the small GTPase Sar1 for intracellular replication","volume":"102","author":"Celli","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0045","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1128\/IAI.66.12.5711-5724.1998","article-title":"Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes","volume":"66","author":"Pizarro-Cerda","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.resmic.2005.10.002","article-title":"Surviving inside a macrophage: the many ways of Brucella","volume":"157","author":"Celli","year":"2006","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1084\/jem.20030088","article-title":"Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum","volume":"198","author":"Celli","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0060","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/AAC.37.11.2333","article-title":"Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin","volume":"37","author":"Lang","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0065","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","article-title":"Nanotechnology as a therapeutic tool to combat microbial resistance","volume":"65","author":"Pelgrift","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000084020","article-title":"The effect of the doxycycline-rifampicin and levamisole combination on lymphocyte subgroups and functions of phagocytic cells in patients with chronic brucellosis","volume":"51","author":"Dizer","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0075","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/clinids\/12.6.1060","article-title":"Modern chemotherapy for brucellosis in humans","volume":"12","author":"Hall","year":"1990","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2018.12.024_bb0080","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.ijantimicag.2010.06.015","article-title":"Update on brucellosis: therapeutic challenges","volume":"36","author":"Solera","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01534-14","article-title":"Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens","volume":"5","author":"Czyz","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0090","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1166\/jbn.2016.2259","article-title":"Cellular internalization mechanisms of polyanhydride particles: implications for rational design of drug delivery vehicles","volume":"12","author":"Phanse","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0095","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jconrel.2015.08.039","article-title":"Nano-enabled delivery of diverse payloads across complex biological barriers","volume":"219","author":"Ross","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0100","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/aaa778","article-title":"Ligand-cascading nano-delivery devices to enable multiscale targeting of anti-neurodegenerative therapeutics","volume":"13","author":"Mullis","year":"2018","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-bioeng-082615-030519","article-title":"Rational design of targeted next-generation carriers for drug and vaccine delivery","volume":"18","author":"Narasimhan","year":"2016","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0110","article-title":"Combinatorial Synthesis of and high-throughput protein release from polymer film and nanoparticle libraries","volume":"67","author":"Petersen","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017642","article-title":"Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases","volume":"6","author":"Ulery","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1021\/cc900116c","article-title":"Novel, high throughput method to study in vitro protein release from polymer nanospheres","volume":"12","author":"Petersen","year":"2010","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0125","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1016\/j.actbio.2010.01.040","article-title":"Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens","volume":"6","author":"Carrillo-Conde","year":"2010","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0130","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1016\/S0142-9612(02)00181-3","article-title":"Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery","volume":"23","author":"Kipper","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0135","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/138620709788923764","article-title":"High throughput cell-based screening of biodegradable polyanhydride libraries","volume":"12","author":"Adler","year":"2009","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/adhm.201200181","article-title":"Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery","volume":"2","author":"Huntimer","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jbm.a.30510","article-title":"Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms","volume":"76","author":"Torres","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0150","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0142-9612(02)00170-9","article-title":"Why degradable polymers undergo surface erosion or bulk erosion","volume":"23","author":"von Burkersroda","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0155","first-page":"2213","article-title":"Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery","volume":"8","author":"Petersen","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0160","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/srep00198","article-title":"Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants","volume":"1","author":"Ulery","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0165","doi-asserted-by":"crossref","first-page":"13770","DOI":"10.1039\/C4NR03724C","article-title":"Effect of nanovaccine chemistry on humoral immune response kinetics and maturation","volume":"6","author":"Haughney","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fimmu.2018.00325","article-title":"Room temperature stable PspA-based nanovaccine induces protective immunity","volume":"9","author":"Wagner-Muniz","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0175","article-title":"Analyzing cellular internalization of nanoparticles and bacteria by multi-spectral imaging flow cytometry","volume":"64","author":"Phanse","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004173","article-title":"Polyanhydride nanoparticle delivery platform dramatically enhances killing of filarial worms","volume":"9","author":"Binnebose","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-3659(02)00125-6","article-title":"Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides","volume":"82","author":"Shen","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2012.00055","article-title":"Host interferon-gamma inducible protein contributes to Brucella survival","volume":"2","author":"Ritchie","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0195","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1128\/IAI.73.6.3702-3713.2005","article-title":"Opsonized virulent Brucella abortus replicates within nonacidic, endoplasmic reticulum-negative, LAMP-1-positive phagosomes in human monocytes","volume":"73","author":"Bellaire","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1574-6968.2009.01530.x","article-title":"Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline","volume":"294","author":"Seleem","year":"2009","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0205","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jac\/dkl289","article-title":"Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB\/c mice","volume":"58","author":"Grillo","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/infdis\/136.4.482","article-title":"Rifampin in the treatment of experimental brucellosis in mice and Guinea pigs","volume":"136","author":"Philippon","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0215","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1128\/AAC.36.5.973","article-title":"Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin","volume":"36","author":"Shasha","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijantimicag.2003.07.005","article-title":"Efficacy of oral levofloxacin and dirithromycin alone and in combination with rifampicin in the treatment of experimental murine Brucella abortus infection","volume":"23","author":"Arda","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0225","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/jbm.b.31478","article-title":"Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres","volume":"91","author":"Lopac","year":"2009","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2004.08.006","article-title":"Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres","volume":"100","author":"Determan","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.12.024_bb0235","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/j.jmb.2016.07.007","article-title":"Avoidance and subversion of eukaryotic homeostatic autophagy mechanisms by bacterial pathogens","volume":"428","author":"Miller","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0240","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkh227","article-title":"Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes","volume":"53","author":"Prior","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0245","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/jac\/dki144","article-title":"Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice","volume":"55","author":"Prior","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0250","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jac\/dkl257","article-title":"Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin","volume":"58","author":"Lecaroz","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0255","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/AAC.00809-06","article-title":"Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice","volume":"51","author":"Lecaroz","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0260","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.actbio.2010.11.031","article-title":"Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections","volume":"7","author":"Imbuluzqueta","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0265","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1128\/AAC.00378-13","article-title":"Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice","volume":"57","author":"Imbuluzqueta","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2018.12.024_bb0270","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00007691-198206000-00001","article-title":"Doxycycline","volume":"4","author":"Cunha","year":"1982","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.024_bb0275","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1208\/s12248-014-9699-z","article-title":"Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles","volume":"17","author":"Vela-Ramirez","year":"2015","journal-title":"AAPS J."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918307272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918307272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:41:07Z","timestamp":1759160467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918307272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":55,"alternative-id":["S0168365918307272"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.024","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotherapeutic provides dose sparing and improved antimicrobial activity against Brucella melitensis infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}